Clinical Trials Logo

Depressive Disorder clinical trials

View clinical trials related to Depressive Disorder.

Filter by:

NCT ID: NCT05644093 Completed - Clinical trials for Major Depressive Disorder

IM and IV SPL026 Drug Product in Healthy Participants

Start date: January 3, 2023
Phase: Phase 1
Study type: Interventional

The goal of this clinical trial is to test SPL026 given via injection into a muscle in healthy volunteers.

NCT ID: NCT05633368 Completed - Covid-19 Clinical Trials

Impact of Covid-19 Pandemic on Patients Receiving Continuation or Maintenance Electroconvulsive Therapy

COVID-M-ECT
Start date: March 31, 2020
Phase:
Study type: Observational

Electroconvulsive therapy is a safe and effective therapeutic strategy in patients with treatment resistant depression. As relapse after successful ECT is significant even with adequate pharmacological strategies, continuation (up to 6 months after completion of index-ECT) or maintenance ECT (more than 6 months after index-ECT) is often necessary to maintain remission. During the current Covid-19 pandemic hospitals redirected resources and closed or significantly diminished ECT services. In this study we aim to assess the impact of discontinuing maintenance electroconvulsive therapy in patients diagnosed with unipolar depressive disorder.

NCT ID: NCT05633186 Completed - Depression Clinical Trials

Sustainable Upscaling of Depression Prevention

Start date: August 31, 2022
Phase: N/A
Study type: Interventional

Research shows that online unguided self-help interventions focused on psycho-education, skills training and lifestyle can prevent mild mood complaints from turning into a full-blown depression. These encouraging results are found even though the adherence to these types of interventions is generally low. With this project, the investigators examine whether effectiveness and adherence to online unguided self-help interventions can be increased by additional motivational guidance elements. This is examined by adding three additional components to the intervention: 1) A coach who provides online feedback once a week to provide support. 2) Mobile application to monitor mood and related factors and to receive automated personalized messages, 3) Content based on the principles of motivational interviewing. A secondary aim is to compare the additional effects of the individual components against the additional costs.

NCT ID: NCT05628675 Completed - Depression Clinical Trials

A Prenatal Bonding Intervention for Pregnant Women With Depression

Start date: November 17, 2022
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to test a group for pregnant women with depression that aims to help them build a stronger relationship with their unborn baby. The main questions it aims to answer are: - Is the group acceptable to pregnant women with depression? - Is it possible to run this group with pregnant women with depression? Participants will be asked to: - attend the group (which lasts 90mins) - complete questionnaires before and after the group, and 1 month later

NCT ID: NCT05615948 Completed - Clinical trials for Major Depressive Disorder

Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression

Start date: December 6, 2022
Phase: Phase 4
Study type: Interventional

The purpose of this study is to assess the effects of simultaneous administration of oral aspirin and oral ketamine as a therapeutic for those with Treatment Resistant Depression.

NCT ID: NCT05601063 Completed - Clinical trials for Attention Deficit Hyperactivity Disorder

Ascertaining Diagnosis Classification With Elicited Speech

ACES
Start date: October 1, 2020
Phase:
Study type: Observational

Cross-sectional observational study of the relationship between speech patterns and psychiatric symptoms and disorders.

NCT ID: NCT05597241 Completed - Clinical trials for Major Depressive Disorder

Multiple Ascending Dose and Electroencephalography Trial of GATE-202 in Healthy Volunteers

Start date: October 15, 2022
Phase: Phase 1
Study type: Interventional

To evaluate the safety, tolerability, pharmacokinetics and EEG pharmacodynamics of single and multiple ascending doses of apimostinel in normal human volunteers

NCT ID: NCT05595512 Completed - Clinical trials for Development of Depression Postpartum

Postpartum Depression

Start date: January 30, 2014
Phase:
Study type: Observational

Postpartum depression (PPD) is one of the most common psychiatric complications of pregnancy and postpartum. It is often defined as an episode of depressive disorder that occurs in the postpartum period. Evidence suggests that PPD has serious consequences on the quality of life of all family members, increases the risk for familial conflicts, leaving great negative effects on maternal-infant interaction. The aim of our study was to investigate and shed the light on the determinants of development of PPD mainly maternal age among women in Jordan. We also aimed at examining additional factors on prevalence of PPD and providing more information on PPD among Jordanian mothers.

NCT ID: NCT05593276 Completed - Depression Clinical Trials

The Preliminary Effects of Empower@Home

Start date: January 5, 2023
Phase: N/A
Study type: Interventional

This randomized pilot trial uses a waitlist control parallel design of a novel internet-based cognitive behavioral therapy program for older adults with elevated depressive symptoms. This study will enroll approximately 35 older adults per group throughout Michigan. The intervention will take approximately ten weeks to complete. Participants will have lower levels of depression after completing the intervention than before enrollment. Participants will be able to use the internet-based platform with minimal support.

NCT ID: NCT05589090 Completed - Anxiety Disorders Clinical Trials

Super Skills for Life Effectiveness in the Online Modality

Start date: October 1, 2017
Phase: N/A
Study type: Interventional

The study aims to evaluate the effectiveness of the transdiagnostic program Super Skills for Life (SSL). This protocol targets children aged 8 to 12 with emotional problems (anxiety, depression, low self-esteem, and lack of social skills). SSL consists of eight sessions targeting common risk factors for internalizing disorders such as cognitive distortions, avoidance, emotional management, low self-esteem, social skills deficits, and coping strategies. The present research focuses on assessing the effectiveness of SSL applied online (through a virtual platform).